Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Has results × Motor Activity × Clear all

Phase

Phase NA 31 Phase 3 3 Phase 2/3 1 Phase 2 1 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Carcinoma, Non-Small-Cell Lung 163 Breast Neoplasms 158 Neoplasms 137 Leukemia, Myeloid, Acute 129 Multiple Myeloma 119 Neoplasm Metastasis 91 Lymphoma 91 Prostatic Neoplasms 90 Melanoma 90 Lymphoma, Non-Hodgkin 84 Leukemia 84 Colorectal Neoplasms 77 Recurrence 71 Pancreatic Neoplasms 70 Lung Neoplasms 70 Ovarian Neoplasms 69 Leukemia, Lymphocytic, Chronic, B-Cell 67 Glioblastoma 66 Myelodysplastic Syndromes 65 Precursor Cell Lymphoblastic Leukemia-Lymphoma 63 Lymphoma, Follicular 59 Lymphoma, Large B-Cell, Diffuse 58 Hodgkin Disease 54 Lymphoma, Mantle-Cell 49 Carcinoma, Renal Cell 49 Brain Neoplasms 48 Carcinoma, Hepatocellular 43 Squamous Cell Carcinoma of Head and Neck 41 Small Cell Lung Carcinoma 41 Triple Negative Breast Neoplasms 40

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05499663 2026-02-06

POSTHOC

University of Maryland, Baltimore

Phase 1/2 Completed

51 enrolled 15 charts

Motor Activity, Neoplasms, Signs and Symptoms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡